FDA Grants Breakthrough Designation to Paige.AI
Expedites Product Development and Provides Priority Regulatory Review For Paige.AI’s Pioneering Clinical-Grade Artificial Intelligence in PathologyRead More
We are very excited to announce that Dr. Leo Grady, a seasoned healthcare technology leader, will be joining Paige.AI as our new Chief Executive Officer and a member of our Board of Directors!
Dr. Leo Grady is a seasoned healthcare technology leader with more than 15 years of experience in prototyping, developing, and bringing to market some of the industry’s most advanced machine learning, computer vision, and medical imaging technologies and products.Read More
Paige.AI Founder, Thomas Fuchs, featured amongst the "Top 100 AI Leaders in Drug Discovery and Advanced Healthcare.”
Dr. Leo Grady is a seasoned healthcare technology leader with more than 15 years of experience in prototyping, developing, and bringing to market some of the industry’s most advanced machine learning, computer vision, and medical imaging technologies and products.Go to Article arrow_forwards
Paige.AI Founder Presents at SPIE Medical Imaging Conference 2019!
The conference is where the latest information is presented by leading researchers in image processing, physics, computer-aided diagnosis, perception, image-guided procedures, biomedical applications, ultrasound, informatics, radiology and digital pathology.Go to Article arrow_forwards
Paige.AI is featured in the CB Insights' 2019 list of 100 most promising AI startups!
The CB Insights research team selected the 100 startups from a pool of 3K+ companies based on several factors, including patent activity, investor profile, news sentiment analysis, proprietary Mosaic scores, market potential, partnerships, competitive landscape, team strength, and tech novelty.Go to Article arrow_forwards
Igneous Partners with Paige.AI To Enhance Industry Leading Compute Cluster for Healthcare AI
Through its partnership with Igneous, Paige.AI will be able to securely and efficiently manage 8 petabytes (PB) of unstructured data as part of an integrated machine learning-based healthcare AI workflow.Go to Article arrow_forwards
Paige.AI Wins the Crain's New York Heritage Research Investigators in Translational Medicine Award
Thomas Fuchs of Paige.AI wins the Crain’s New York Heritage Research Investigators in Translational Medicine Award. Our team is humbled and inspired by this recognition!Go to Article arrow_forwards
With Training, Startups Like Paige.AI Could Soon Diagnose Cancer
Xconomy discusses the future applications of AI in cancer diagnosis, featuring Paige.AI's founder, Thomas Fuchs.Go to Article arrow_forwards
Superstar VC's Bet on American and Chinese Artificial Intelligence
Jim Breyer talks to Forbes about the AI landscape and the importance of collaboration between great computer scientists and experts in specific domains, like cancer research.Go to Article arrow_forwards
Paige.AI Forms One of the Largest Compute Clusters in Pathology and Healthcare, Enabling Deep Learning at Remarkable New Scale
Our high-performance computer cluster is built on the AIRI, a high performance, fully integrated software and hardware solution by Pure Storage and NVIDIA.Go to Article arrow_forwards
Paige.AI Presents at Global Audience of Machine Learning Experts
At GTC 2018, one of the largest gatherings around AI and machine learning, our founder, Thomas Fuchs, spoke about the importance of harnessing technology to augment human ingenuity, particularly in Pathology.Go to Article arrow_forwards
Paige.AI officially launched!
Paige.AI officially launches today as it aims to revolutionize pathology through AI. It is buoyed by a comprehensive license agreement with Memorial Sloan Kettering Cancer Center (MSK) to gain exclusive rights to MSK’s library of 25 million pathology slides, as well as $25 million from a successful Series A funding round to build the leading offering in digital and computational pathology.Go to Article arrow_forwards
Plenary Talk and Panel at the 24th Prostate Cancer Foundation Scientific Retreat
Artificial Intelligence and Genomic were center stage at the 24th Prostate Cancer Foundation Scientific Retreat. PAIGE's Founder Thomas Fuchs gave a plenary talk on Computational Pathology and participated in a panel discussion about how the potential of AI can be realized in prostate cancer research.Go to Article arrow_forwards
Launch of the Warren Alpert Center for Digital and Computational Pathology
The Warren Alpert Center for Digital and Computational Pathology at MSKCC was established in 2017 as an innovation center to facilitate novel research and development in digital pathology and computational pathology for clinical cancer care and research. Paige.AI's founder Thomas Fuchs serves as center director for Computational Pathology.Go to Article arrow_forwards
How AI detectives are cracking open the black box of deep learning
Science produced a beautiful video explaining the inner workings of deep neural networks and how to open the black box, based on a paper by Jason Yosinski and our CSO Thomas Fuchs.Go to Article arrow_forwards
A Reality Check for IBM's AI Ambitions
Paige.AI's founder gave an interview about the challenges of AI in medicine in general and in Computational Pathology in particular.Go to Article arrow_forwards
NVIDIA's AI in Healthcare Summit 2017
Paige.AI's founder, Thomas, was invited to speak at NVIDIA's GTC AI in Healthcare Summit.Go to Article arrow_forwards
How does PAIGE work?
Learn about our technology and how PAIGE is revolutionizing pathology.About Paige